Table 3.

Analysis of MTHFR genotypes in children with ALL and controls


MTHFR genotypes




C677T
A1298C
ALL patients, no. (%)
Controls, no. (%)
OR (95% CI)
P
CC   AA   51 (18.9)   35 (11.7)   1.0 (referent)   —  
CT   AA   69 (25.6)   69 (23.0)   0.7 (0.4-1.2)   .2  
TT   AA   31 (11.5)   46 (15.3)   0.4 (0.2-0.9)   .02  
CC   AC   49 (18.1)   60 (20.0)   0.6 (0.3-1.0)   .06  
CT   AC   58 (21.5)   59 (19.7)   0.7 (0.4-1.2)   .2  
CC
 
CC
 
12 (4.4)
 
31 (10.3)
 
0.3 (0.1-0.6)
 
< .001
 

MTHFR genotypes




C677T
A1298C
ALL patients, no. (%)
Controls, no. (%)
OR (95% CI)
P
CC   AA   51 (18.9)   35 (11.7)   1.0 (referent)   —  
CT   AA   69 (25.6)   69 (23.0)   0.7 (0.4-1.2)   .2  
TT   AA   31 (11.5)   46 (15.3)   0.4 (0.2-0.9)   .02  
CC   AC   49 (18.1)   60 (20.0)   0.6 (0.3-1.0)   .06  
CT   AC   58 (21.5)   59 (19.7)   0.7 (0.4-1.2)   .2  
CC
 
CC
 
12 (4.4)
 
31 (10.3)
 
0.3 (0.1-0.6)
 
< .001
 

The risk of ALL for the CC677/AA1298 individuals compared with all other genotypes is 1.8 (95% CI, 1.1-2.8; P = .02). No individual with the following genotypes was observed: TT677/AC1298, TT677/CC1298, and CT677/CC1298.

OR indicates crude odds ratio; CI, confidence interval; and —, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal